![Charles T. Roberts](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles T. Roberts
Fondatore presso DiabetOmics, Inc.
Posizioni attive di Charles T. Roberts
Società | Posizione | Inizio | Fine |
---|---|---|---|
DiabetOmics, Inc.
![]() DiabetOmics, Inc. Medical/Nursing ServicesHealth Services DiabetOmics, Inc. provides diabetes care services. It engages in the non-invasive assessment and management of personalized health and diabetes risk, progression and complications. The firm?s services include personalized wellness profile with laboratory tests, action plan for disease prevention and identifying conditions that may be present before symptoms occur. The company was founded by Srinivasa Rao Nagalla, Paturi V. Rao and Charles Roberts in 2008 and is headquartered in Hillsboro, OR. | Direttore Tecnico/Scientifico/R&S | 01/01/2008 | - |
Fondatore | 01/01/2008 | - |
Storia della carriera di Charles T. Roberts
Precedenti posizioni note di Charles T. Roberts
Società | Posizione | Inizio | Fine |
---|---|---|---|
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/01/1994 | 01/01/1994 |
ProteoGenix, Inc.
![]() ProteoGenix, Inc. Medical SpecialtiesHealth Technology ProteoGenix is the first and only company solely committed to developing minimally invasive diagnostics that address unmet medical needs and improve pregnancy and neonatal management and outcomes. By applying innovative proteomic and molecular technologies, ProteoGenix has quickly become a leader in developing powerful diagnostic tools that have the potential to dramatically change the future of pregnancy and neonatal management. In 2002, four leading researchers in the area of perinatology and neonatology joined together to create ProteoGenix, a company dedicated to solving the mysteries of preterm birth and the significant medical, emotional and economic consequences that prematurity has on their society. Their passion for improving pregnancy management and the outcomes associated with preterm birth, along with their clinical expertise and scientific acumen, led ProteoGenix to achieve a truly significant recent scientific discovery identification of The Proteomic Map of Pregnancy. The physicians and scientists that became ProteoGenix were the first to identify and characterize a fundamental map of the key biologic fluids in pregnancy and show how this landscape changes in important pregnancy-related disorders. This groundbreaking work has received several significant scientific awards, including Best Clinical Study at the 2007 annual meeting of the Society for Maternal-Fetal Medicine, and has been the topic of numerous peer-reviewed publications. ProteoGenix has also developed the unique capability to utilize sophisticated nucleic acid-based molecular microbiology techniques such as quantitative Polymerase Chain Reaction (PCR) and Pyrosequencing, specifically optimized for use in key maternal, fetal, neonatal biological fluids to detect infectious and path physiological diseases associated with pregnancy. | Fondatore | 02/01/2002 | - |
Oregon Health & Science University | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Corporate Officer/Principal | 2 |
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Services | 2 |
Government | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
DiabetOmics, Inc.
![]() DiabetOmics, Inc. Medical/Nursing ServicesHealth Services DiabetOmics, Inc. provides diabetes care services. It engages in the non-invasive assessment and management of personalized health and diabetes risk, progression and complications. The firm?s services include personalized wellness profile with laboratory tests, action plan for disease prevention and identifying conditions that may be present before symptoms occur. The company was founded by Srinivasa Rao Nagalla, Paturi V. Rao and Charles Roberts in 2008 and is headquartered in Hillsboro, OR. | Health Services |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
ProteoGenix, Inc.
![]() ProteoGenix, Inc. Medical SpecialtiesHealth Technology ProteoGenix is the first and only company solely committed to developing minimally invasive diagnostics that address unmet medical needs and improve pregnancy and neonatal management and outcomes. By applying innovative proteomic and molecular technologies, ProteoGenix has quickly become a leader in developing powerful diagnostic tools that have the potential to dramatically change the future of pregnancy and neonatal management. In 2002, four leading researchers in the area of perinatology and neonatology joined together to create ProteoGenix, a company dedicated to solving the mysteries of preterm birth and the significant medical, emotional and economic consequences that prematurity has on their society. Their passion for improving pregnancy management and the outcomes associated with preterm birth, along with their clinical expertise and scientific acumen, led ProteoGenix to achieve a truly significant recent scientific discovery identification of The Proteomic Map of Pregnancy. The physicians and scientists that became ProteoGenix were the first to identify and characterize a fundamental map of the key biologic fluids in pregnancy and show how this landscape changes in important pregnancy-related disorders. This groundbreaking work has received several significant scientific awards, including Best Clinical Study at the 2007 annual meeting of the Society for Maternal-Fetal Medicine, and has been the topic of numerous peer-reviewed publications. ProteoGenix has also developed the unique capability to utilize sophisticated nucleic acid-based molecular microbiology techniques such as quantitative Polymerase Chain Reaction (PCR) and Pyrosequencing, specifically optimized for use in key maternal, fetal, neonatal biological fluids to detect infectious and path physiological diseases associated with pregnancy. | Health Technology |
- Borsa valori
- Insiders
- Charles T. Roberts
- Esperienza